Drug delivery systems for CRISPR-based genome editors
V Madigan, F Zhang, JE Dahlman - Nature Reviews Drug Discovery, 2023 - nature.com
CRISPR-based drugs can theoretically manipulate any genetic target. In practice, however,
these drugs must enter the desired cell without eliciting an unwanted immune response, so …
these drugs must enter the desired cell without eliciting an unwanted immune response, so …
[HTML][HTML] Metazoan micrornas
DP Bartel - Cell, 2018 - cell.com
MicroRNAs (miRNAs) are∼ 22 nt RNAs that direct posttranscriptional repression of mRNA
targets in diverse eukaryotic lineages. In humans and other mammals, these small RNAs …
targets in diverse eukaryotic lineages. In humans and other mammals, these small RNAs …
Endothelial cells in the pathogenesis of pulmonary arterial hypertension
Pulmonary arterial hypertension (PAH) is a devastating disease that involves pulmonary
vasoconstriction, small vessel obliteration, large vessel thickening and obstruction, and …
vasoconstriction, small vessel obliteration, large vessel thickening and obstruction, and …
Emerging frontiers in drug delivery
Medicine relies on the use of pharmacologically active agents (drugs) to manage and treat
disease. However, drugs are not inherently effective; the benefit of a drug is directly related …
disease. However, drugs are not inherently effective; the benefit of a drug is directly related …
Iron metabolism in cancer
Y Wang, L Yu, J Ding, Y Chen - International journal of molecular …, 2018 - mdpi.com
Demanded as an essential trace element that supports cell growth and basic functions, iron
can be harmful and cancerogenic though. By exchanging between its different oxidized …
can be harmful and cancerogenic though. By exchanging between its different oxidized …
Vascular stiffness mechanoactivates YAP/TAZ-dependent glutaminolysis to drive pulmonary hypertension
Dysregulation of vascular stiffness and cellular metabolism occurs early in pulmonary
hypertension (PH). However, the mechanisms by which biophysical properties of the …
hypertension (PH). However, the mechanisms by which biophysical properties of the …
MicroRNA-210 controls mitochondrial metabolism and protects heart function in myocardial infarction
Background: Ischemic heart disease remains a leading cause of death worldwide. In this
study, we test the hypothesis that microRNA-210 protects the heart from myocardial …
study, we test the hypothesis that microRNA-210 protects the heart from myocardial …
Barcoded nanoparticles for high throughput in vivo discovery of targeted therapeutics
JE Dahlman, KJ Kauffman, Y Xing… - Proceedings of the …, 2017 - National Acad Sciences
Nucleic acid therapeutics are limited by inefficient delivery to target tissues and cells and by
an incomplete understanding of how nanoparticle structure affects biodistribution to off …
an incomplete understanding of how nanoparticle structure affects biodistribution to off …
Identification of microRNA-124 as a major regulator of enhanced endothelial cell glycolysis in pulmonary arterial hypertension via PTBP1 (polypyrimidine tract binding …
P Caruso, BJ Dunmore, K Schlosser, S Schoors… - Circulation, 2017 - Am Heart Assoc
Background: Pulmonary arterial hypertension (PAH) is characterized by abnormal growth
and enhanced glycolysis of pulmonary artery endothelial cells. However, the mechanisms …
and enhanced glycolysis of pulmonary artery endothelial cells. However, the mechanisms …
Mitochondria in lung disease
SM Cloonan, AMK Choi - The Journal of clinical …, 2016 - Am Soc Clin Investig
Mitochondria are a distinguishing feature of eukaryotic cells. Best known for their critical
function in energy production via oxidative phosphorylation (OXPHOS), mitochondria are …
function in energy production via oxidative phosphorylation (OXPHOS), mitochondria are …